NEU 0.00% $19.97 neuren pharmaceuticals limited

Acadia, page-383

  1. 1,381 Posts.
    lightbulb Created with Sketch. 284
    Neuren’s quarterly report indicated that Acadia expected to file for Canadian registration of Trofinitide in q1.
    With the end of q1 nearing are we likely to see notification by either Acadia or Health Canada that it has been successfully submitted?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.